Glucagon-like peptide-1 analog

WikiDoc Resources for Glucagon-like peptide-1 analog
Articles
Most recent articles on Glucagon-like peptide-1 analog Most cited articles on Glucagon-like peptide-1 analog Review articles on Glucagon-like peptide-1 analog Articles on Glucagon-like peptide-1 analog in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Glucagon-like peptide-1 analog Images of Glucagon-like peptide-1 analog Photos of Glucagon-like peptide-1 analog Podcasts & MP3s on Glucagon-like peptide-1 analog Videos on Glucagon-like peptide-1 analog
Evidence Based Medicine
Cochrane Collaboration on Glucagon-like peptide-1 analog Bandolier on Glucagon-like peptide-1 analog TRIP on Glucagon-like peptide-1 analog
Clinical Trials
Ongoing Trials on Glucagon-like peptide-1 analog at Clinical Trials.gov Trial results on Glucagon-like peptide-1 analog Clinical Trials on Glucagon-like peptide-1 analog at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Glucagon-like peptide-1 analog NICE Guidance on Glucagon-like peptide-1 analog NHS PRODIGY Guidance FDA on Glucagon-like peptide-1 analog CDC on Glucagon-like peptide-1 analog
Books
Books on Glucagon-like peptide-1 analog
News
Glucagon-like peptide-1 analog in the news Be alerted to news on Glucagon-like peptide-1 analog News trends on Glucagon-like peptide-1 analog
Commentary
Blogs on Glucagon-like peptide-1 analog
Definitions
Definitions of Glucagon-like peptide-1 analog
Patient Resources / Community
Patient resources on Glucagon-like peptide-1 analog Discussion groups on Glucagon-like peptide-1 analog Patient Handouts on Glucagon-like peptide-1 analog Directions to Hospitals Treating Glucagon-like peptide-1 analog Risk calculators and risk factors for Glucagon-like peptide-1 analog
Healthcare Provider Resources
Symptoms of Glucagon-like peptide-1 analog Causes & Risk Factors for Glucagon-like peptide-1 analog Diagnostic studies for Glucagon-like peptide-1 analog Treatment of Glucagon-like peptide-1 analog
Continuing Medical Education (CME)
CME Programs on Glucagon-like peptide-1 analog
International
Glucagon-like peptide-1 analog en Espanol Glucagon-like peptide-1 analog en Francais
Business
Glucagon-like peptide-1 analog in the Marketplace Patents on Glucagon-like peptide-1 analog
Experimental / Informatics
List of terms related to Glucagon-like peptide-1 analog

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Glucagon-like peptide-1 analogs are a new class of drug for treatment of type 2 diabetes. One of their advantages is that they have a lower risk of causing hypoglycemia.

Licenced:

• exenatide (2005)

Under investigation:

• albiglutide
• taspoglutide